May 9 | 2022 2cureX presents IndiTreat® clinical results at the Society for Functional Precision Medicine Read more
May 6 | 2022 2cureX appoints Sedermera Corporate Finance AB to act as a liquidity provider for the Company´s share Read more
May 6 | 2022 2cureX utser Sedermera Corporate Finance AB till likviditetsgarant för bolagets aktie Read more
April 29 | 2022 Rättelse: Korrektion till “Kallelse till årsstämma i 2cureX AB” utfärdad den 21 april 2022 Read more
April 22 | 2022 Correction of “Notice of annual general meeting of 2cureX AB (publ)” issued on 21st April 2022 Read more
April 22 | 2022 Korrektion till “Kallelse till årsstämma i 2cureX AB” utfärdad den 21 april 2022 Read more
April 21 | 2022 Manuel Fernández joins 2cureX as Director of Quality Assurance and Regulatory Affairs. Read more
April 14 | 2022 Chairman of the 2cureX Board exercises all warrants within the framework of the 2018 incentive program Read more